Stock·NASDAQ·Financial Services
Northern Trust Corporation (NTRS)
- Market cap
- $30.29B
- P/E
- 14.63
- Dividend yield
- 1.98%
- Street target
- $184.50median of 16 analysts
- 52-week range
- $121.53 $195.78
The short version
Where NTRS stands today, in four lines, and what CleaRank Financial AI makes of it.
NTRS at a glance
Northern Trust Corporation (NTRS): Hold, 55/100 on CleaRank's AI score.
- Trend Mixed: the price is above its 200-day but below its 50-day moving average ($164.21 and $179.52).
- Earnings NTRS beat estimates in 7 of its last 8 quarters, yet fell the next day after 3 of those beats.
- Insiders Insiders sold $20.2M and bought $846K over the last 18 months.
- Valuation P/E of 14.6 against 16.5 for the Financial Services sector: broadly in line with peers (-11%).
Figures as of October 17, 2026.
CleaRank Financial AI
Northern Trust Corporation (NTRS) carries a CleaRank rating of Hold and a model score of 55/100.
Revenue growth is the factor that lifts the score most, with sales up 36.40%, 24.7 percentage points faster than the sector median. Momentum drags the score down most: the 14-day RSI of 34.6 sits in the bearish zone and the MACD line is negative. The trend is mixed, with the stock 7.79% below its 50-day average of $179.52 yet 0.81% above its 200-day average of $164.21. Looking back a year, the price climbed 32.89%.
Only on CleaRank
Figures we compute ourselves from NTRS's own price, earnings and insider-filing history. Tap one to see it in context.
Price and trading
The chart, today's range and how far the price has moved over each period.
Trend checks
3/4Price above its 50-day average ›
The price of $165.54 is 7.8% below the 50-day simple moving average of $179.52.Price above its 200-day average ›
The price is 0.8% above the 200-day simple moving average of $164.21.50-day average above the 200-day ›
The 50-day average ($179.52) is 9.3% above the 200-day average ($164.21), the arrangement of a rising longer-term trend.In the upper half of its 52-week range ›
The price sits at 59% of its 52-week range, between $121.53 and $195.78.
NTRS share price
Pick a period: each tab shows how far NTRS has moved over it, to the last close.
Today's trading
Where NTRS sits inside today's range and its 52-week range.
Fundamentals
Valuation against the sector, and the revenue and earnings behind it.
Valuation and quality checks
5/5P/E below the sector median ›
The trailing P/E of 14.63 is 11.3% below the Financial Services median of 16.5.P/S below the sector median ›
The price-to-sales ratio of 3.33 is 12.3% below the sector median of 3.8.Profitable over the last 12 months ›
Net income over the last 12 months was $2.2B on revenue of $9.1B, a net margin of 24.0%.Beat estimates in most recent reports ›
NTRS beat the EPS estimate in 7 of its last 8 reports.Pays a dividend ›
The trailing dividend yield is 1.98%, or $3.28 a share a year.
Key statistics
The headline figures for NTRS.
As of October 17, 2026, NTRS trades at $165.54, with a market value of $30.29B, a P/E ratio of 14.63 and a dividend yield of 1.98%.
What the numbers say
CleaRank Financial AI's reading of NTRS's valuation, growth and risks.
NTRS trades at 14.63 times earnings, compared with a Financial Services median of 16.5. That makes the P/E 11.3% below the sector median P/E, and the P/E is broadly in line with peers. Measured against sales, the P/S of 3.33 is 12.4% below the sector median P/S of 3.8. The company has a market value of $30.3B and trailing earnings of $11.31 per share.
Revenue grew 36.40% in the latest year, which is 24.7 percentage points faster than the sector median of 11.7%. Profitability is strong, with a net margin of 24.67% and an operating margin of 42.50%. Return on equity is 17.07%, above the sector median of 13.8%. Debt-to-equity stands at 0.01, and the trailing dividend yield is 1.98%, or $3.28 a share a year.
The July 22, 2026 report missed expectations by 8.44%: EPS of $4.23 against an estimate of $4.62. The share price fell 0.40% in the first session after the report.
Over its last 8 reports, NTRS topped the estimate 7 times, though the stock still fell in the first session after 3 of those 7 beats. The consensus EPS estimate stands at $12.62 for this fiscal year and $12.71 for next, growth of 44.4% for the current year.
Daily moves in NTRS are modest: the price typically shifts by 1.33%, measured as the 30-day standard deviation of daily returns. The stock is still 15.45% under its 52-week high of $195.78.
NTRS against the Financial Services sector
How NTRS compares with the median Financial Services stock CleaRank tracks.
Price to earnings vs sector: Valuation is broadly in line with sector peers (-11% difference), suggesting fair market pricing relative to industry standards.
Return vs XLF: Since May 6, 2025, NTRS has gained 70.9% against a gain of 12.9% for XLF.
Performance against XLF
NTRS and the Financial Services sector fund over the same days.
Revenue and earnings
How much NTRS sells, and how much of it becomes profit.
Revenue growth: Revenue fell 2.5% in FY2025 to $8.1B, from $8.3B a year earlier.
Profit margin: The net margin was 21.5% in FY2025, down from 24.5% the year before.
Profitable: NTRS earned $1.7B in FY2025.
Earnings reality check
Did NTRS beat what analysts expected, and how did the stock react?
Earnings record: NTRS beat the analyst estimate in 7 of the last 8 quarters.
Market reaction: The stock fell in the first session after 3 of those 7 beats, so a beat has not been enough on its own.
| Report | Estimate | Actual | Surprise | First session | 5 sessions |
|---|---|---|---|---|---|
| Jul 22, 2026after close | $4.62 | $4.23 | -8.44% | -0.40% | -0.57% |
| Apr 21, 2026after close | $2.33 | $2.71 | +16.31% | -2.28% | -2.82% |
| Jan 22, 2026after close | $2.37 | $2.42 | +2.11% | -2.93% | -1.61% |
| Oct 22, 2025after close | $2.24 | $2.29 | +2.23% | -0.59% | +1.42% |
| Jul 23, 2025after close | $2.04 | $2.13 | +4.41% | +3.65% | +5.90% |
| Apr 22, 2025after close | $1.84 | $1.90 | +3.26% | +1.39% | +5.25% |
| Jan 23, 2025after close | $2.00 | $2.26 | +13.00% | +1.26% | +2.92% |
| Oct 23, 2024after close | $1.93 | $2.22 | +15.03% | +0.27% | -1.02% |
As of October 17, 2026, NTRS has beaten the analyst EPS estimate in 7 of its last 8 reported quarters and fell in the first trading session after 3 of those beats; its latest report, on July 22, 2026, came in 8.44% below the estimate and the stock moved -0.40% in the first session.
The first session is the first full trading day on the news: the report day itself for a report before the open, the next day for one after the close. Surprise is actual EPS against the consensus estimate.
AI analysis and technicals
CleaRank's score and reasoning, the indicators behind it, and what the price moves with.
Momentum checks
1/3RSI not overbought or oversold ›
The 14-day RSI is 34.6, showing bearish momentum without being oversold.RSI above 50 ›
An RSI of 34.6 is below the 50 midpoint, so sellers have had the upper hand over the last 14 days.MACD line above zero ›
The MACD line is negative, so the 12-day average is below the 26-day average.
CleaRank AI analysis of NTRS
The score, the reasoning behind it, and what could move the price next.
Northern Trust Corporation (NTRS) is trading in the middle of its two main moving averages. The price of $165.54 is 0.81% above its 200-day average of $164.21, yet 7.79% below its 50-day average of $179.52. Across the 52-week range, which runs from $121.53 to $195.78, the stock currently sits at 59% of the way up.
The stock has pulled back inside a longer record that is still positive. Over the past month the price fell 6.28%, and over the past three months it fell 10.36%, yet over the past year it rose 32.89%. The 14-day RSI sits at 34.6, in the bearish zone but not yet oversold, and the MACD line is negative. In the last session the price rose 0.06% on volume that was 105.1% above its average.
Rating reaffirmed ›
TD Cowen kept its Hold rating on October 8, 2026.
Source: Analyst action, TD Cowen, October 8, 2026
Earnings miss ›
The July 22, 2026 report missed the EPS estimate by 8.44%, and the share price fell 0.40% in the first session after it.
Source: Earnings report, July 22, 2026
- The two closest levels to watch are the 20-day EMA at $170.52, which sits above the price, and the 200-day SMA at $164.21, which sits below it.
- A 14-day RSI of 34.6 falls in the bearish zone, and the MACD line is negative. Readings above 70 or below 30 are where momentum becomes stretched.
- NTRS fell 0.40% in the first session after its July 22, 2026 report, even though it beat estimates in 7 of the last 8 reports.
NTRS is in a mixed trend: the price sits above its 200-day average at $164.21 but below its 50-day average at $179.52. A close above the 50-day would turn both signals up, while a close below the 200-day would turn both down. For now the price is held between the 200-day SMA at $164.21 underneath and the 20-day EMA at $170.52 overhead.
With the RSI in the bearish zone, momentum is working against a quick rebound in NTRS.
Technical indicators
Momentum and trend for NTRS, from its daily closes.
As of October 17, 2026, with NTRS at $165.54, its 14-day RSI is 34.6 (showing bearish momentum without being oversold), its 50-day simple moving average is $179.52 and its 200-day is $164.21.
Calculated by CleaRank on daily closes as of October 17, 2026: Wilder's 14-day RSI, 50- and 200-day simple moving averages, MACD line (12, 26).
What NTRS moves with
Correlation of daily returns over one year: +1 moves in step, 0 has no link, -1 moves the opposite way.
As of October 17, 2026, NTRS's 1-year correlation of daily returns is +0.62 with S&P 500 (SPY), +0.51 with Nasdaq 100 (QQQ), +0.28 with Bitcoin (BTC) and +0.10 with gold (XAU).
What Wall Street expects
The analysts' target range and how their ratings split.
Analysts checks
1/3Most analysts rate it a buy ›
2 of 16 analysts rate it a buy or strong buy, 12 a hold and 2 a sell.Median target above the price ›
The median 12-month target of $184.50 is 11.5% above the price.More buy ratings than three months ago ›
2 of 16 rate it a buy now, against 2 of 15 three months ago.
NTRS Wall Street View
12-month price targets
Ratings
Recent rating actions
| Date | Firm | Action | Rating |
|---|---|---|---|
| Oct 8, 2026 | TD Cowen | Reinstates | Hold |
| Oct 6, 2026 | BMO Capital | Maintains | Outperform |
| Oct 5, 2026 | Citigroup | Maintains | Neutral |
| Oct 2, 2026 | JP Morgan | Maintains | Neutral |
| Oct 1, 2026 | Evercore ISI Group | Maintains | In-Line |
| Aug 4, 2026 | JP Morgan | Maintains | Neutral |
As of October 17, 2026, 16 Wall Street analysts cover NTRS: 2 rate it a buy or strong buy, 12 a hold and 2 a sell or strong sell. Their 12-month price targets range from $158.00 to $194.00, with a median of $184.50, 11.5% above the price of $165.54.
Source: TwelveData analyst consensus. Targets and ratings belong to the analysts, not to CleaRank.
A trade plan, if you want one
Entry, stop and target levels from the moving averages and recent volatility. Educational, not advice.
NTRS trade plan
Entry, stop and target levels, sized to your account. Change the bias or the risk and every level updates.
Entry Strategies pick an entry style
Risk management
Profit targets (Based on Conservative Entry)
These levels come from NTRS's moving averages and recent volatility, not from a forecast. Educational levels, not financial advice; the full disclaimer is at the foot of the page.
Risk profile
How much NTRS tends to move, against the market and on its own.
The long record
NTRS's worst falls and recoveries, what $10,000 became, and which months have been kind to it.
Track record checks
2/4Average daily move under 2% ›
The price has moved 1.33% on an average day (30-day standard deviation of daily returns).Recovered from its worst fall ›
The worst fall was 49.0%, from January 2022 to October 2023, regained by June 2025.Most 1-year holds ended higher ›
59% of 1-year holding periods in the last 10 years ended with a gain.Beat the S&P 500 since the chart begins ›
$10,000 invested in October 2016 is now worth $30,823, against $42,055 in the S&P 500 (SPY).
NTRS Drawdowns & Recovery
As of October 17, 2026, NTRS's worst peak-to-trough fall over the last 10 years with dividends reinvested was -49.0% (January 2022 to October 2023); it regained that peak by June 2025, 20 months after the low, and 59% of 1-year holding periods ended with a gain.
From weekly closing values with dividends reinvested. A drawdown is the fall from the highest value reached so far to a later low.
Growth of $10,000
What $10,000 put into NTRS in October 2016 is worth now, against the same amount in the S&P 500.
Against the market: NTRS trailed the S&P 500 over this period: $30,823 against $42,055.
A $10,000 investment in NTRS in October 2016 would be worth about $30,823 today with dividends reinvested, compared with about $42,055 for the same investment in the S&P 500 benchmark (also with dividends reinvested).
Seasonal patterns
Which calendar months have been kind to NTRS, and which have not.
Strongest month, November: an average of +9.25%, up in 9 of 10 years.
Weakest month, March: an average of -2.45%, up in 3 of 10 years.
This month, October: has averaged +0.66%, up in 4 of 9 years. Past seasonality does not repeat on schedule.
Over the last 10 years, NTRS's strongest calendar month has been November (average +9.25%, up in 9 of 10 years) and its weakest March (average -2.45%, up in 3 of 10 years).
Average return for each calendar month over the last 10 years, from weekly closing prices with dividends included.
Long-term scenarios
Thousands of simulated paths from the price history. A range of outcomes, not a forecast.
Monte Carlo projection
Thousands of simulated paths for $10,000 in NTRS, from its own past volatility. The shaded area holds 80% of them.
CleaRank's 10-year Monte Carlo simulation projects that a $10,000 investment in NTRS today could grow to about $20,356 by 2036 in the base case, with a 90th-percentile outcome near $69,736 and a 10th-percentile outcome around $5,942. The simulation models price only; at today's 1.98% yield, dividends would add to these figures. Projections are statistical simulations, not guarantees.
NTRS Stock Price Prediction: 2030
The same simulation in share prices, year by year.
CleaRank's simulation projects a price near $220 for NTRS by 2030 in the base case, from $166 today (1.3x over 4 years). The 10th-percentile path ends near $101. These are outcomes of a Monte Carlo simulation run on NTRS's historical return distribution, not price targets, and they assume no dividends are reinvested.
| Year | 10th percentile | Base case | 90th percentile | range base today |
|---|---|---|---|---|
| 2027 | $120 | $178 | $262 | |
| 2028 | $110 | $191 | $331 | |
| 2029 | $104 | $205 | $402 | |
| 2030 | $101 | $220 | $479 | |
| 2031 | $98.88 | $236 | $564 |
Method: a lognormal simulation of NTRS's own volatility and capped historical trend, re-run daily; base case is the median path, the outer columns the 10th and 90th percentiles.
Insider trading
What the people running the company have bought and sold.
NTRS insider trading
Shares the company's directors and officers bought and sold, from their own filings.
Month by month
Open-market purchases above the line, sales below.
Insider buying: Insiders bought $846K on the open market and sold $20.2M.
As of October 17, 2026, NTRS insiders reported 19 open-market sales worth $20.2M and 8 open-market purchases worth $846K over the last 18 months; grants and option exercises are not counted.
| Date | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Aug 24, 2026 | Thomas A South
Officer
|
Sell | 1.8K | $332.8K |
| Jul 29, 2026 | Robert Edward Moritz Jr.
Director
|
Buy | 255 | $45.8K |
| Jul 1, 2026 | Chandra Dhandapani
Director
|
Grant | 227 | $39.6K |
| Jul 1, 2026 | Dean M Harrison
Director
|
Grant | 389 | $68.0K |
| Jul 1, 2026 | Marcy S Klevorn
Director
|
Grant | 57 | $10.0K |
| Jul 1, 2026 | Siddharth N Mehta
Director
|
Grant | 26 | $4.7K |
| Jul 1, 2026 | Richard Petrino
Director
|
Grant | 5 | $946 |
| Jul 1, 2026 | Martin P Slark
Director
|
Grant | 61 | $10.8K |
| Jul 1, 2026 | Donald Thompson
Director
|
Grant | 341 | $59.6K |
| Jul 1, 2026 | Charles A Tribbett III
Director
|
Grant | 69 | $12.3K |
| Jun 3, 2026 | Aengus Hallinan
Officer
|
Sell | 3.7K | $613.9K |
| May 22, 2026 | Thomas A South
Officer
|
Grant | 320 | - |
| May 4, 2026 | Thomas A South
Officer
|
Grant | 1.3K | - |
| May 1, 2026 | Robert Edward Moritz Jr.
Director
|
Buy | 225 | $37.4K |
| Apr 29, 2026 | David W Fox Jr
Chief Financial Officer
|
Sell | 20.0K | $3.3M |
| Apr 24, 2026 | Clive Bellows
Officer
|
Sell | 2.8K | $462.1K |
| Apr 21, 2026 | Chandra Dhandapani
Director
|
Grant | 1.0K | $6.0K |
| Apr 21, 2026 | Dean M Harrison
Director
|
Grant | 1.0K | $6.0K |
| Apr 21, 2026 | Jay L. Henderson
Director
|
Grant | 989 | - |
| Apr 21, 2026 | Marcy S Klevorn
Director
|
Grant | 1.0K | $6.0K |
| Apr 21, 2026 | Siddharth N Mehta
Director
|
Grant | 1.0K | $6.0K |
| Apr 21, 2026 | Robert Edward Moritz Jr.
Director
|
Grant | 989 | - |
| Apr 21, 2026 | Richard Petrino
Director
|
Grant | 1.0K | $3.0K |
| Apr 21, 2026 | Martin P Slark
Director
|
Grant | 1.0K | $6.0K |
| Apr 21, 2026 | David Byron Smith Jr.
Director
|
Grant | 989 | - |
| Apr 21, 2026 | Donald Thompson
Director
|
Grant | 1.0K | $6.0K |
| Apr 21, 2026 | Charles A Tribbett III
Director
|
Grant | 989 | - |
| Apr 1, 2026 | Susan Crown
Director
|
Grant | 82 | $11.7K |
| Apr 1, 2026 | Chandra Dhandapani
Director
|
Grant | 270 | $37.8K |
| Apr 1, 2026 | Dean M Harrison
Director
|
Grant | 471 | $66.1K |
| Apr 1, 2026 | Marcy S Klevorn
Director
|
Grant | 59 | $8.4K |
| Apr 1, 2026 | Siddharth N Mehta
Director
|
Grant | 22 | $3.2K |
| Apr 1, 2026 | Richard Petrino
Director
|
Grant | 2 | $344 |
| Apr 1, 2026 | Martin P Slark
Director
|
Grant | 65 | $9.2K |
| Apr 1, 2026 | Donald Thompson
Director
|
Grant | 411 | $57.7K |
| Apr 1, 2026 | Charles A Tribbett III
Director
|
Grant | 86 | $12.2K |
| Mar 4, 2026 | David W Fox Jr
Chief Financial Officer
|
Sell | 3.3K | $468.4K |
| Feb 25, 2026 | David W Fox Jr
Chief Financial Officer
|
Sell | 1.5K | $208.9K |
| Feb 17, 2026 | Peter B Cherecwich
Chief Operating Officer
|
Grant | 26.3K | - |
| Feb 17, 2026 | David W Fox Jr
Chief Financial Officer
|
Grant | 2.6K | - |
| Feb 17, 2026 | Susan Cohen Levy
General Counsel
|
Grant | 16.5K | - |
| Feb 17, 2026 | Grady Michael G O
Chief Executive Officer
|
Grant | 72.6K | - |
| Feb 17, 2026 | Thomas A South
Officer
|
Grant | 19.9K | - |
| Feb 17, 2026 | Alexandria Taylor
Officer
|
Grant | 6.4K | - |
| Feb 17, 2026 | Jason J Tyler
Officer
|
Grant | 21.5K | - |
| Feb 13, 2026 | Jason J Tyler
Officer
|
Option | 4.6K | $267.9K |
| Feb 12, 2026 | Clive Bellows
Officer
|
Sell | 1.1K | $166.8K |
| Feb 5, 2026 | Clive Bellows
Officer
|
Grant | 7.8K | - |
| Feb 5, 2026 | Peter B Cherecwich
Chief Operating Officer
|
Grant | 8.0K | - |
| Feb 5, 2026 | David W Fox Jr
Chief Financial Officer
|
Grant | 6.4K | - |
| Feb 5, 2026 | Aengus Hallinan
Officer
|
Grant | 4.0K | - |
| Feb 5, 2026 | Michael R. Hunstad
Officer
|
Grant | 4.5K | - |
| Feb 5, 2026 | John P. Landers
Officer
|
Grant | 801 | - |
| Feb 5, 2026 | Susan Cohen Levy
General Counsel
|
Grant | 4.7K | - |
| Feb 5, 2026 | Grady Michael G O
Officer and Director
|
Grant | 19.4K | - |
| Feb 5, 2026 | Richard Petrino
Director
|
Buy | 1.0K | $148.9K |
| Feb 5, 2026 | Thomas A South
Officer
|
Grant | 16.9K | - |
| Feb 5, 2026 | Alexandria Taylor
Officer
|
Grant | 5.7K | - |
| Feb 5, 2026 | Jason J Tyler
Officer
|
Grant | 7.2K | - |
| Feb 2, 2026 | Robert Edward Moritz Jr.
Director
|
Buy | 245 | $37.2K |
| Jan 29, 2026 | Grady Michael G O
Chief Executive Officer
|
Option | 34.5K | $2.0M |
| Jan 26, 2026 | Peter B Cherecwich
Chief Operating Officer
|
Sell | 25.0K | $3.7M |
| Dec 31, 2025 | Chandra Dhandapani
Director
|
Grant | 275 | $37.6K |
| Dec 31, 2025 | Dean M Harrison
Director
|
Grant | 480 | $65.7K |
| Dec 31, 2025 | Marcy S Klevorn
Director
|
Grant | 61 | $8.4K |
| Dec 31, 2025 | Siddharth N Mehta
Director
|
Grant | 22 | $3.1K |
| Dec 31, 2025 | Richard Petrino
Director
|
Grant | 2 | $341 |
| Dec 31, 2025 | Martin P Slark
Director
|
Grant | 67 | $9.2K |
| Dec 31, 2025 | Donald Thompson
Director
|
Grant | 420 | $57.4K |
| Dec 31, 2025 | Charles A Tribbett III
Director
|
Grant | 88 | $12.1K |
| Dec 11, 2025 | Thomas A South
Officer
|
Sell | 5.0K | $695.2K |
| Dec 11, 2025 | Thomas A South
Officer
|
Grant | 80 | - |
| Dec 10, 2025 | David W Fox Jr
Chief Financial Officer
|
Grant | 1.9K | - |
| Nov 17, 2025 | John P. Landers
Officer
|
Sell | 766 | $95.3K |
| Nov 6, 2025 | Steven L Fradkin
Officer
|
Sell | 9.4K | $1.2M |
| Nov 4, 2025 | Susan Cohen Levy
General Counsel
|
Sell | 27.6K | $3.5M |
| Nov 4, 2025 | Susan Cohen Levy
General Counsel
|
Option | 27.6K | $1.6M |
| Nov 4, 2025 | Robert Edward Moritz Jr.
Director
|
Buy | 3.9K | $500.3K |
| Oct 27, 2025 | Robert Edward Moritz Jr.
Director
|
Buy | 270 | $34.2K |
| Oct 1, 2025 | Chandra Dhandapani
Director
|
Grant | 277 | $37.3K |
| Oct 1, 2025 | Dean M Harrison
Director
|
Grant | 489 | $65.3K |
| Oct 1, 2025 | Marcy S Klevorn
Director
|
Grant | 63 | $8.3K |
| Oct 1, 2025 | Siddharth N Mehta
Director
|
Grant | 23 | $3.1K |
| Oct 1, 2025 | Richard Petrino
Director
|
Grant | 2 | $340 |
| Oct 1, 2025 | Martin P Slark
Director
|
Grant | 69 | $9.1K |
| Oct 1, 2025 | Donald Thompson
Director
|
Grant | 427 | $57.0K |
| Oct 1, 2025 | Charles A Tribbett III
Director
|
Grant | 91 | $12.1K |
| Sep 9, 2025 | Thomas A South
Officer
|
Grant | 155 | - |
| Aug 25, 2025 | David W Fox Jr
Chief Financial Officer
|
Grant | 191 | - |
| Aug 13, 2025 | Robert Edward Moritz Jr.
Director
|
Buy | 256 | $32.3K |
| Jul 31, 2025 | Teresa A Parker
Officer
|
Sell | 7.6K | $997.5K |
| Jul 30, 2025 | Steven L Fradkin
Officer
|
Sell | 21.7K | $2.8M |
| Jul 1, 2025 | Chandra Dhandapani
Director
|
Grant | 282 | $35.8K |
| Jul 1, 2025 | Dean M Harrison
Director
|
Grant | 493 | $62.8K |
| Jul 1, 2025 | Marcy S Klevorn
Director
|
Grant | 60 | $7.8K |
| Jul 1, 2025 | Siddharth N Mehta
Director
|
Grant | 22 | $2.9K |
| Jul 1, 2025 | Richard Petrino
Director
|
Grant | 2 | $317 |
| Jul 1, 2025 | Martin P Slark
Director
|
Grant | 66 | $8.5K |
| Jul 1, 2025 | Donald Thompson
Director
|
Grant | 433 | $55.2K |
| Jul 1, 2025 | Charles A Tribbett III
Director
|
Grant | 87 | $11.2K |
| May 22, 2025 | Aengus Hallinan
Officer
|
Sell | 5 | $528 |
| May 22, 2025 | Thomas A South
Officer
|
Grant | 500 | - |
| May 19, 2025 | Aengus Hallinan
Officer
|
Grant | 11.8K | - |
| May 12, 2025 | David W Fox Jr
Chief Financial Officer
|
Sell | 5.1K | $535.8K |
| May 12, 2025 | Kelley Conway
Officer
|
Sell | 500 | $52.6K |
| May 9, 2025 | Teresa A Parker
Officer
|
Sell | 6.5K | $650.7K |
| May 8, 2025 | Clive Bellows
Officer
|
Sell | 3.3K | $329.8K |
| Apr 24, 2025 | Robert Edward Moritz Jr.
Director
|
Buy | 112 | $10.3K |
| Apr 22, 2025 | Jay L. Henderson
Director
|
Grant | 1.9K | - |
| Apr 22, 2025 | Marcy S Klevorn
Director
|
Grant | 2.0K | $11.8K |
| Apr 22, 2025 | Siddharth N Mehta
Director
|
Grant | 2.0K | $6.9K |
| Apr 22, 2025 | Robert Edward Moritz Jr.
Director
|
Grant | 1.9K | - |
| Apr 22, 2025 | David Byron Smith Jr.
Director
|
Grant | 1.9K | - |
Source: TwelveData, from SEC Form 4 filings
Questions people ask
Answered from the figures on this page, as of October 17, 2026.